Skip to Content

PAD 135 (Hydrochlorothiazide and Moexipril Hydrochloride 25 mg / 15 mg)

Pill with imprint PAD 135 is Yellow, Elliptical / Oval and has been identified as Hydrochlorothiazide and Moexipril Hydrochloride 25 mg / 15 mg. It is supplied by Paddock Laboratories, Inc..

Hydrochlorothiazide/moexipril is used in the treatment of high blood pressure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/moexipril 25 mg / 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for PAD 135

Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg PAD 135

Hydrochlorothiazide and Moexipril Hydrochloride

Imprint
PAD 135
Strength
25 mg / 15 mg
Color
Yellow
Size
14.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Ace inhibitors with thiazides
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Paddock Laboratories, Inc.
National Drug Code (NDC)
00574-0135
Inactive Ingredients
lactose, magnesium oxide, crospovidone, magnesium stearate, povidone, silicon dioxide, hypromelloses, titanium dioxide, polyethylene glycol 400, ferric oxide red

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.